NCT02205320View on ClinicalTrials.gov

A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions
Pharmacokinetics
Interventions
BIOLOGICAL

DRL_PG

BIOLOGICAL

Pegfilgrastim Form A

BIOLOGICAL

Pegfilgrastim Form B

Trial Locations (1)

65802

RECRUITING

QPS Bio-Kinetic, Springfield

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY